Exact Mass: 563.5277
Exact Mass Matches: 563.5277
Found 125 metabolites which its exact mass value is equals to given mass value 563.5277
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cer(d18:1/18:1(9Z))
Ceramides (N-acylsphingosine) are one of the hydrolysis byproducts of sphingomyelin by the enzyme sphingomyelinase (sphingomyelin phosphorylcholine phosphohydrolase E.C.3.1.4.12) which has been identified in the subcellular fractions of human epidermis (PMID 25935) and many other tissues. They can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID 14998372). Is key in the biosynthesis of glycosphingolipids and gangliosides. Ceramide (D18:1/9Z-18:1) is found to be associated with Fabry disease, which is an inborn error of metabolism. Ceramides (N-acylsphingosine) are one of the hydrolysis byproducts of sphingomyelin by the enzyme sphingomyelinase (sphingomyelin phosphorylcholine phosphohydrolase E.C.3.1.4.12) which has been identified in the subcellular fractions of human epidermis (PMID 25935) and many other tissues. They can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID 14998372). Is key in the biosynthesis of glycosphingolipids and gangliosides. [HMDB]
Cer(d18:1/18:1(11Z))
Ceramides (N-acylsphingosine) are one of the hydrolysis byproducts of sphingomyelin by the enzyme sphingomyelinase (sphingomyelin phosphorylcholine phosphohydrolase E.C.3.1.4.12) which has been identified in the subcellular fractions of human epidermis (PMID 25935) and many other tissues. They can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID 14998372). Is key in the biosynthesis of glycosphingolipids and gangliosides. [HMDB] Ceramides (N-acylsphingosine) are one of the hydrolysis byproducts of sphingomyelin by the enzyme sphingomyelinase (sphingomyelin phosphorylcholine phosphohydrolase E.C.3.1.4.12) which has been identified in the subcellular fractions of human epidermis (PMID 25935) and many other tissues. They can also be synthesized from serine and palmitate in a de novo pathway and are regarded as important cellular signals for inducing apoptosis (PMID 14998372). Is key in the biosynthesis of glycosphingolipids and gangliosides.
Cer[NS] d36:2
Found in mouse brain; TwoDicalId=162; MgfFile=160720_brain_normal_01_Neg; MgfId=1041
(2SR,3RS,4E,8E)-2-(14-methylheptadecanoylamino)-1,3-dihydroxy-4,8-octadecadiene
(4E,6E,2S,3R)-2-N-docosanoyl-4,6-tetradecasphingadienine
N-[1.3-dihydroxyoctadeca-4.14-dien-2-yl]octadecanimidic acid
N-[(4E,8E)-1,3-dihydroxyoctadeca-4,8-dien-2-yl]octadecanamide
(2S,3R,4E,8E)-2-(Octadecanoylamino)-4,8-octadecadiene-1,3-diol
(9Z,12Z)-N-(1,3-dihydroxyoctadecan-2-yl)octadeca-9,12-dienamide
N-[(4E,8E)-1,3-dihydroxytritriaconta-4,8-dien-2-yl]propanamide
N-[(4E,8E)-1,3-dihydroxyhentriaconta-4,8-dien-2-yl]pentanamide
(Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]octacos-17-enamide
N-[(4E,8E)-1,3-dihydroxytetratriaconta-4,8-dien-2-yl]acetamide
N-[(4E,8E)-1,3-dihydroxydotriaconta-4,8-dien-2-yl]butanamide
N-[(4E,8E)-1,3-dihydroxyheptacosa-4,8-dien-2-yl]nonanamide
N-[(4E,8E)-1,3-dihydroxynonacosa-4,8-dien-2-yl]heptanamide
N-[(4E,8E)-1,3-dihydroxytriaconta-4,8-dien-2-yl]hexanamide
(17Z,20Z)-N-(1,3-dihydroxyoctan-2-yl)octacosa-17,20-dienamide
N-[(4E,8E)-1,3-dihydroxyoctacosa-4,8-dien-2-yl]octanamide
N-[(4E,8E)-1,3-dihydroxypentacosa-4,8-dien-2-yl]undecanamide
(15Z,18Z)-N-(1,3-dihydroxydecan-2-yl)hexacosa-15,18-dienamide
(9Z,12Z)-N-(1,3-dihydroxyheptadecan-2-yl)nonadeca-9,12-dienamide
(11Z,14Z)-N-(1,3-dihydroxypentadecan-2-yl)henicosa-11,14-dienamide
N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]tetracosanamide
(Z)-N-[(E)-1,3-dihydroxytricos-4-en-2-yl]tridec-9-enamide
(Z)-N-[(E)-1,3-dihydroxyicos-4-en-2-yl]hexadec-9-enamide
N-[(4E,8E)-1,3-dihydroxyhexacosa-4,8-dien-2-yl]decanamide
(13Z,16Z)-N-(1,3-dihydroxytetradecan-2-yl)docosa-13,16-dienamide
(Z)-N-[(E)-1,3-dihydroxynonadec-4-en-2-yl]heptadec-9-enamide
(Z)-N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]docos-13-enamide
(13Z,16Z)-N-(1,3-dihydroxydodecan-2-yl)tetracosa-13,16-dienamide
N-[(4E,8E)-1,3-dihydroxytrideca-4,8-dien-2-yl]tricosanamide
(9Z,12Z)-N-(1,3-dihydroxynonadecan-2-yl)heptadeca-9,12-dienamide
(Z)-N-[(E)-1,3-dihydroxypentadec-4-en-2-yl]henicos-11-enamide
(Z)-N-[(E)-1,3-dihydroxydodec-4-en-2-yl]tetracos-13-enamide
(9Z,12Z)-N-(1,3-dihydroxyicosan-2-yl)hexadeca-9,12-dienamide
(Z)-N-[(E)-1,3-dihydroxydec-4-en-2-yl]hexacos-15-enamide
N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]docosanamide
N-[(4E,8E)-1,3-dihydroxyicosa-4,8-dien-2-yl]hexadecanamide
N-[(4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]henicosanamide
(Z)-N-[(E)-1,3-dihydroxyhenicos-4-en-2-yl]pentadec-9-enamide
(Z)-N-[(E)-1,3-dihydroxyheptadec-4-en-2-yl]nonadec-9-enamide
(Z)-N-[(E)-1,3-dihydroxyhexadec-4-en-2-yl]icos-11-enamide
N-[(4E,8E)-1,3-dihydroxydocosa-4,8-dien-2-yl]tetradecanamide
N-[(4E,8E)-1,3-dihydroxytetracosa-4,8-dien-2-yl]dodecanamide
N-[(4E,8E)-1,3-dihydroxyhenicosa-4,8-dien-2-yl]pentadecanamide
(11Z,14Z)-N-(1,3-dihydroxyhexadecan-2-yl)icosa-11,14-dienamide
N-[(4E,8E)-1,3-dihydroxynonadeca-4,8-dien-2-yl]heptadecanamide
(Z)-N-[(E)-1,3-dihydroxydocos-4-en-2-yl]tetradec-9-enamide
N-[(4E,8E)-1,3-dihydroxyhexadeca-4,8-dien-2-yl]icosanamide
N-[(4E,8E)-1,3-dihydroxytricosa-4,8-dien-2-yl]tridecanamide
N-[(4E,8E)-1,3-dihydroxyheptadeca-4,8-dien-2-yl]nonadecanamide
(Z)-N-[(E)-1,3-dihydroxyoctadec-4-en-2-yl]octadec-11-enamide
(Z)-N-[(E)-1,3-dihydroxytricos-4-en-2-yl]tridec-8-enamide
(Z)-N-[(E)-1,3-dihydroxytetracos-4-en-2-yl]dodec-5-enamide
(Z)-N-[(E)-1,3-dihydroxypentadec-4-en-2-yl]henicos-9-enamide
(4Z,7Z)-N-(1,3-dihydroxyicosan-2-yl)hexadeca-4,7-dienamide
(14Z,16Z)-N-(1,3-dihydroxytetradecan-2-yl)docosa-14,16-dienamide
(10Z,12Z)-N-(1,3-dihydroxyoctadecan-2-yl)octadeca-10,12-dienamide
(Z)-N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]docos-11-enamide
(Z)-N-[(E)-1,3-dihydroxyicos-4-en-2-yl]hexadec-7-enamide
(E)-N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]octadec-9-enamide
(E)-N-[(E,2S,3R)-1,3-dihydroxytetradec-8-en-2-yl]docos-13-enamide
(E)-N-[(E,2S,3R)-1,3-dihydroxyicos-8-en-2-yl]hexadec-9-enamide
(E)-N-[(E,2S,3R)-1,3-dihydroxynonadec-8-en-2-yl]heptadec-9-enamide
N-[(2S,3R,4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]docosanamide
N-[(2S,3R,4E,8E)-1,3-dihydroxyicosa-4,8-dien-2-yl]hexadecanamide
N-[(2S,3R,4E,8E)-1,3-dihydroxypentadeca-4,8-dien-2-yl]henicosanamide
(9E,12E)-N-[(2S,3R)-1,3-dihydroxyoctadecan-2-yl]octadeca-9,12-dienamide
(E)-N-[(E,2S,3R)-1,3-dihydroxyicos-4-en-2-yl]hexadec-9-enamide
(E)-N-[(E,2S,3R)-1,3-dihydroxyhexadec-4-en-2-yl]icos-11-enamide
(E)-N-[(E,2S,3R)-1,3-dihydroxynonadec-4-en-2-yl]heptadec-9-enamide
N-[(2S,3R,4E,14E)-1,3-dihydroxyoctadeca-4,14-dien-2-yl]octadecanamide
N-[(2S,3R,4E,6E)-1,3-dihydroxypentadeca-4,6-dien-2-yl]henicosanamide
(E)-N-[(E,2S,3R)-1,3-dihydroxytetradec-4-en-2-yl]docos-13-enamide
N-[(2S,3R,4E,8E)-1,3-dihydroxydocosa-4,8-dien-2-yl]tetradecanamide
(E)-N-[(E,2S,3R)-1,3-dihydroxyoctadec-8-en-2-yl]octadec-9-enamide
N-[(2S,3R,4E,8E)-1,3-dihydroxyhenicosa-4,8-dien-2-yl]pentadecanamide
N-[(2S,3R,4E,8E)-1,3-dihydroxynonadeca-4,8-dien-2-yl]heptadecanamide
N-[(2S,3R,4E,8E)-1,3-dihydroxyhexadeca-4,8-dien-2-yl]icosanamide
(E)-N-[(E,2S,3R)-1,3-dihydroxyhexadec-8-en-2-yl]icos-11-enamide
N-[(2S,3R,4E,8E)-1,3-dihydroxyheptadeca-4,8-dien-2-yl]nonadecanamide
N-Oleoylsphingosine
A N-acylsphingosine in which the ceramide N-acyl group is specified as oleoyl.
N-octadecanoyl-(4E,14Z)-sphingadienine
A N-acyl-(4E,14Z)-sphingadienine in which the N-acyl group is specified as octadecanoyl.